Process Engineering STREAM

  1. Enhanced API Solubility And Stable, High Drug Loads 4/12/2017

    Poor solubility of APIs is a critical challenge in drug development. One formulation technique to address this challenge is hot melt extrusion.

  2. A Closed And Automated Solution For Cell Therapy Manufacturing 3/1/2024

    Streamline your cell therapy manufacturing process and workflow by automating and closing your cell isolation, cell harvest, and formulation with a system designed to offer you versatility.

  3. Small-Scale Oligonucleotide Synthesizer That Supports Scale Up 2/16/2023

    Learn about a small oligonucleotide synthesizer with big impact that features a user-friendly interface, compact footprint, and more. This small scale system is user friendly and supports scale up.

  4. How To Best Optimize mRNA Production Workflows 4/11/2023

    Multiple steps in the mRNA manufacturing process can appear more complex than they have to be. Learn how to simplify your approach and produce the best possible mRNA vaccines and therapeutics.

  5. OsmoTECH® HT Automated Micro-Osmometer 12/14/2021

    The automation-friendly OsmoTECH HT, the only plate-based micro-osmometer, is designed in a 96 well format that ensures efficiency and acceleration of osmolality testing in early upstream process development, formulation development and stability testing.

  6. Navigating The Workflow From Process Development To GMP Manufacturing For Making Clonal iPSC-Derived Master Cell Banks 3/7/2022

    In this video, we present data for optimizing choices of which combinations of GMP-compatible matrix, dissociation reagents, and media can best be employed for single cell cloning of iPSCs in process development.

  7. Parteck® SRP 80 - Reliable Sustained Drug Delivery 8/9/2017

    Parteck® SRP 80, a functional excipient based on polyvinyl alcohol (PVA), provides reliable sustained drug delivery over long release periods.

  8. Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D. 10/20/2025

    In this episode of "Better Biopharma," host Tyler Menichiello is joined by MindImmune's president and CEO, Stevin Zorn, Ph.D. They discuss the development of the company's lead candidate, MITI-101, a monoclonal antibody designed to prevent peripheral immune cells from entering the brain and driving neuroinflammation linked to Alzheimer's disease.

  9. Collaboration & Expertise, The Keys To Efficiency And Scalability Across All Modalities 7/8/2022

    View this video and discover our global vaccine capabilities from process development to full-scale GMP-manufacturing and in all modalities.

  10. Accelerating Novel Cell Therapies To Market 3/20/2024

    Learn about two matrices that, when combined, provide an optimal solution for the process development and manufacturing of novel induced pluripotent stem cell therapies.